tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
Holding FDMT?
Track your performance easily

4D Molecular Therapeutics (FDMT) Financial Statements

287 Followers

4D Molecular Therapeutics Financial Overview

4D Molecular Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.734; its P/E ratio is -3.08; 4D Molecular Therapeutics is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 3.00K$ 5.00K$ 28.00K$ -18.00K$ 20.20M
Gross Profit$ 3.00K$ 5.00K$ 28.00K$ -18.00K$ 20.20M
EBIT$ -43.84M$ -34.95M$ -32.40M$ -36.65M$ -13.97M
EBITDA$ -42.14M$ -32.57M$ -31.56M$ -35.14M$ -12.58M
Net Income Common Stockholders$ -43.84M$ -34.95M$ -32.40M$ -32.28M$ -10.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 501.89M$ 541.95M$ 525.91M$ 288.23M$ 319.66M
Total Assets$ 604.03M$ 620.12M$ 629.88M$ 339.89M$ 361.61M
Total Debt$ 24.83M$ 13.66M$ 14.17M$ 14.67M$ 15.16M
Net Debt$ -477.06M$ -528.29M$ -511.74M$ -273.56M$ -304.51M
Total Liabilities$ 51.08M$ 31.78M$ 29.32M$ 32.06M$ 31.68M
Stockholders Equity$ 552.95M$ 588.32M$ 600.56M$ 307.83M$ 329.93M
Cash Flow-
Free Cash Flow$ -31.17M$ -30.59M$ -29.80M$ -25.20M$ -1.58M
Operating Cash Flow$ -29.39M$ -30.24M$ -29.09M$ -24.65M$ -1.17M
Investing Cash Flow$ 27.30M$ -73.54M$ -263.26M$ -6.68M$ 29.98M
Financing Cash Flow$ 568.00K$ 17.25M$ 318.83M$ 4.76M$ 10.56M
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History

4D Molecular Therapeutics Debt to Assets

4D Molecular Therapeutics Cash Flow

4D Molecular Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis